STOCK ALARM
PRO
SA
PRO
Explore
Screener
Alerts
Themes
Research
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Charles River Laboratories International, Inc.
CRL
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$4B
↓1%
Gross Profit
$1B
↓8%
Operating Income
$508M
↑123%
Net Income
$-144M
↓1502%
EBITDA
$911M
↑57%
EPS Diluted
-2.9
Cost of Revenue
$3B
Gross Margin %
30.5%
R&D Expenses
$0
SG&A Expenses
$743M
Operating Expenses
$718M
Operating Margin %
12.6%
Interest Expense
$107M
Income Before Tax
$-100M
Income Tax Expense
$43M
Net Margin %
-3.6%
EPS
-2.9
Shares Out (Diluted)
49.6M
Shares Out (Basic)
49.6M
Total Costs & Expenses
$4B
Interest Income
$5M
EBITDA Margin %
22.7%
Pre-Tax Margin %
-2.5%
Other Income/Expenses
$-607M
Revenue CAGR (5Y)
+6.5%
Margin Trend
declining
Free Cash Flow
$0.5B
Profitability
Now unprofitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
3,540
3,976
↑12.3%
4,129
↑3.9%
4,050
↓1.9%
4,015
↓0.9%
Gross Profit
1,335
1,463
↑9.6%
1,503
↑2.7%
1,332
↓11.4%
1,226
↓8.0%
Operating Income
590
651
↑10.4%
617
↓5.2%
227
↓63.2%
508
↑123.4%
Net Income
391
486
↑24.4%
475
↓2.4%
10
↓97.8%
-144
↓1501.7%
EBITDA
820
986
↑20.2%
1,032
↑4.7%
581
↓43.7%
911
↑56.8%
EPS Diluted
7.60
9.48
↑24.7%
9.22
↓2.7%
0.20
↓97.8%
-2.91
↓1555.0%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages